GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Scivision Biotech Inc (TPE:1786) » Definitions » Cyclically Adjusted PB Ratio

Scivision Biotech (TPE:1786) Cyclically Adjusted PB Ratio : 4.10 (As of Jun. 03, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Scivision Biotech Cyclically Adjusted PB Ratio?

As of today (2025-06-03), Scivision Biotech's current share price is NT$95.40. Scivision Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was NT$23.24. Scivision Biotech's Cyclically Adjusted PB Ratio for today is 4.10.

The historical rank and industry rank for Scivision Biotech's Cyclically Adjusted PB Ratio or its related term are showing as below:

TPE:1786' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.02   Med: 3.4   Max: 6.02
Current: 4.14

During the past years, Scivision Biotech's highest Cyclically Adjusted PB Ratio was 6.02. The lowest was 2.02. And the median was 3.40.

TPE:1786's Cyclically Adjusted PB Ratio is ranked worse than
75.65% of 497 companies
in the Medical Devices & Instruments industry
Industry Median: 1.87 vs TPE:1786: 4.14

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Scivision Biotech's adjusted book value per share data for the three months ended in Mar. 2025 was NT$24.159. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$23.24 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Scivision Biotech Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Scivision Biotech's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scivision Biotech Cyclically Adjusted PB Ratio Chart

Scivision Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.60 2.72 2.65 3.51 4.54

Scivision Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.32 5.87 5.78 4.54 4.65

Competitive Comparison of Scivision Biotech's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Scivision Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scivision Biotech's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Scivision Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Scivision Biotech's Cyclically Adjusted PB Ratio falls into.


;
;

Scivision Biotech Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Scivision Biotech's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=95.40/23.24
=4.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scivision Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Scivision Biotech's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=24.159/134.9266*134.9266
=24.159

Current CPI (Mar. 2025) = 134.9266.

Scivision Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201506 16.245 100.684 21.770
201509 15.693 100.392 21.091
201512 15.549 99.792 21.023
201603 15.242 100.470 20.469
201606 14.835 101.688 19.684
201609 14.075 101.861 18.644
201612 14.906 101.863 19.744
201703 14.327 102.862 18.793
201706 14.345 103.349 18.728
201709 14.887 104.136 19.289
201712 15.243 104.011 19.774
201803 15.814 105.290 20.265
201806 15.702 106.317 19.927
201809 17.014 106.507 21.554
201812 17.464 105.998 22.230
201903 20.597 107.251 25.912
201906 19.574 108.070 24.438
201909 19.960 108.329 24.861
201912 20.558 108.420 25.584
202003 21.107 108.902 26.151
202006 20.247 108.767 25.117
202009 20.761 109.815 25.508
202012 21.214 109.897 26.046
202103 21.587 111.754 26.063
202106 22.064 114.631 25.970
202109 21.483 115.734 25.046
202112 21.905 117.630 25.126
202203 22.313 121.301 24.819
202206 21.494 125.017 23.198
202209 22.182 125.227 23.900
202212 22.827 125.222 24.596
202303 23.864 127.348 25.284
202306 22.555 128.729 23.641
202309 23.572 129.860 24.492
202312 24.022 129.419 25.044
202403 22.665 131.776 23.207
202406 24.855 132.554 25.300
202409 25.959 133.029 26.329
202412 26.424 133.157 26.775
202503 24.159 134.927 24.159

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Scivision Biotech  (TPE:1786) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Scivision Biotech Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Scivision Biotech's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Scivision Biotech Business Description

Traded in Other Exchanges
N/A
Address
No. 1, South 1st Road, KEPZ, Kaohsiung, TWN, 806
Scivision Biotech Inc is engaged in the manufacturing and distribution of hyaluronic acid medical supplies in Taiwan. It offers medical devices, including absorbable adhesion barriers, dermal implants, synovial fluid supplements, and intravesical instillation.

Scivision Biotech Headlines

No Headlines